Quick Answer
GE HealthCare Technologies Inc. reported Net Income Loss of $2.08 billion for the year ending 2025.
- GE HealthCare Technologies Inc. showed an increase of +4.6% in Net Income Loss from 2024 to 2025.
- This data is from GE HealthCare Technologies Inc.'s annual report (Form 10-K), filed with the SEC on February 4, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $389.00 million | Q2 2022: $485.00 million | Q3 2022: $487.00 million | Q1 2023: $372.00 million | Q2 2023: $418.00 million | Q3 2023: $375.00 million | Q1 2024: $374.00 million | Q2 2024: $428.00 million | Q3 2024: $470.00 million | Q1 2025: $564.00 million | Q2 2025: $486.00 million | Q3 2025: $446.00 million.
- Over the full 5 years of available data (2021 to 2025), GE HealthCare Technologies Inc.'s Net Income Loss has declined by 7.3%.
- Historical annual values: Fiscal year 2025: $2.08 billion | Fiscal year 2024: $1.99 billion | Fiscal year 2023: $1.57 billion | Fiscal year 2022: $1.92 billion | Fiscal year 2021: $2.25 billion.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: